• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharmaceuticals

Hi-Tech Pharmacal Co Inc

+ Add to Watchlist


31.110 EUR 0.060 0.19%

As of 02:08:24 ET on 04/17/2014.

Snapshot for Hi-Tech Pharmacal Co Inc (HT6)

Open: 31.337 Day's Range: 31.110 - 31.337 Volume: 0
Previous Close: 31.170 52wk Range: 22.630 - 32.928 1-Yr Rtn: +22.60%

Stock Chart for HT6

No chart data available.
  • HT6:GR 31.337
  • 1D
  • 1M
  • 1Y
Interactive HT6 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for HT6

Current P/E Ratio (ttm) -
Estimated P/E(04/2014) 18.0608
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (04/2014) 2.3800
Est. PEG Ratio -
Market Cap (M EUR) 432.65
Shares Outstanding (M) 13.91
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 1.5000
Dividend Ex-Date 12/11/2012
5 Year Dividend Growth -
Next Earnings Announcement 07/09/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for HT6

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for HT6

Hi-Tech Pharmacal Co., Inc. manufactures prescription and over-the-counter generic and branded pharmaceuticals in liquid and semi-solid dosage forms. The Company also manufactures sterile ophthalmic, otic, and inhalation products and provides sterile manufacturing contract services. Hi-Tech markets its own products under names such as H-T, Rx Choice, DiabetiDerm, and Steri-Optics.

David S SeltzerChairman/Pres/CEO/TreasurerReuben SeltzerVice Chairman
Kamel EgbariaExec VP/Chief Scientific OfcrWilliam J PetersVP/CFO
More Company Profile & Key Executives for HT6

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Links
sec ||= nil